Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Simpson, Melissa ^a   Snell Bergeon, Janet K ^a   Kinney, Gregory L ^a   Lache, Orit ^b   Miller Lotan, Rachel ^b   Anbinder, Yefim ^b   Rewers, Marian J ^a   Levy, Andrew P ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cardiovascular disease; Coronary artery calcium; Genetics; Haptoglobin; Hyperglycemia; Type 1 diabetes mellitus

Indexed keywords

HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIABETIC PATIENT; DISEASE COURSE; DISEASE MARKER; FEMALE; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSPECTIVE STUDY; BLOOD VESSEL CALCIFICATION; CASE CONTROL STUDY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHENOTYPE; PREDICTIVE VALUE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; COLORADO; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPTOGLOBINS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 81255172201     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-99     Document Type: Article

References (26)

1. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. The American journal of cardiology 1987, 59:750-755. 10.1016/0002-9149(87)91086-1, 3825934.
2. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003, 46:760-765. 10.1007/s00125-003-1116-6, 12774166.
3. Farbstein D, Levy AP. The genetics of vascular complications in diabetes mellitus. Cardiology clinics 2010, 28:477-496. 10.1016/j.ccl.2010.04.005, 2904316, 20621252.
4. Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. The American journal of cardiology 1994, 74:1272-1274. 10.1016/0002-9149(94)90563-0, 7977105.
5. Raggi P, Cooil B, Shaw LJ, Aboulhson J, Takasu J, Budoff M, Callister TQ. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. The American journal of cardiology 2003, 92:827-829. 10.1016/S0002-9149(03)00892-0, 14516885.
6. Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, Demoss D, Nuguri V, Nabavi V, Ratakonda R, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovascular imaging 2010, 3:1229-1236.
7. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, et al. Haptoglobin: basic and clinical aspects. Antioxidants & redox signaling 2010, 12:293-304. 10.1089/ars.2009.2793, 22105806.
8. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Advances in human genetics 1982, 12:189-261. 453-184.
9. Costacou T, Ferrell RE, Orchard TJ. Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes. Diabetes 2008, 57:1702-1706. 10.2337/db08-0095, 18332093.
10. Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. Journal of the American College of Cardiology 2002, 40:1984-1990. 10.1016/S0735-1097(02)02534-2, 12475459.
11. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K. Haptoglobin phenotype and vascular complications in patients with diabetes. The New England journal of medicine 2000, 343:969-970. 10.1056/NEJM200009283431313, 11012324.
12. Roguin A, Koch W, Kastrati A, Aronson D, Schomig A, Levy AP. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes care 2003, 26:2628-2631. 10.2337/diacare.26.9.2628, 12941730.
13. Suleiman M, Aronson D, Asleh R, Kapeliovich MR, Roguin A, Meisel SR, Shochat M, Sulieman A, Reisner SA, Markiewicz W, et al. Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. Diabetes 2005, 54:2802-2806. 10.2337/diabetes.54.9.2802, 16123372.
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. Journal of the American College of Cardiology 1990, 15:827-832. 10.1016/0735-1097(90)90282-T, 2407762.
15. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003, 52:2833-2839. 10.2337/diabetes.52.11.2833, 14578303.
16. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR American journal of roentgenology 2004, 182:1327-1332.
17. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schomig A, Kastrati A. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clinical chemistry 2002, 48:1377-1382.
18. Victor J CW, Chen JS, Levy N, Miller-Lotan R, Levy AP, Blum S, Orchard TJ, Evans RW, Costacou T, Hauth BA. Clinical Results of a Rapid Screening Assay for Haptoglobin 2-2: A Cardiovascular Disease Risk Marker (abstract). American Diabetes Association 69th Scientific Sessions; New Orleans LA. Diabetes 2009, 652-P.
19. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. Journal of the American College of Cardiology 2006, 47:C13-18. 10.1016/j.jacc.2005.10.065, 16631505.
20. Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP. Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circulation research 2005, 96:435-441. 10.1161/01.RES.0000156653.05853.b9, 15662028.
21. Asleh R, Blum S, Kalet-Litman S, Alshiek J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, et al. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes 2008, 57:2794-2800. 10.2337/db08-0450, 2551691, 18599520.
22. Delanghe JR, Langlois MR, De Buyzere ML. Haptoglobin polymorphism: a key factor in the proatherogenic role of B cells?. Atherosclerosis 2011, 217:80-82. 10.1016/j.atherosclerosis.2011.03.031, 21507405.
23. Haas B, Serchi T, Wagner DR, Gilson G, Planchon S, Renaut J, Hoffmann L, Bohn T, Devaux Y. Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker. Journal of proteomics 2011,
24. Asaf R, Blum S, Roguin A, Kalet-Litman S, Kheir J, Frisch A, Miller-Lotan R, Levy AP. Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice. Cardiovascular diabetology 2009, 8:29. 10.1186/1475-2840-8-29, 2694779, 19490627.
25. Blum S, Vardi M, Brown JB, Russell A, Milman U, Shapira C, Levy NS, Miller-Lotan R, Asleh R, Levy AP. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics 2010, 11:675-684. 10.2217/pgs.10.17, 2880717, 20415560.
26. Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arteriosclerosis, thrombosis, and vascular biology 2008, 28:341-347.